Fortis Healthcare to sell RadLink for over Rs 530 cr

By: Pharma News | Views: 958 | Date: 31-May-2015

Wrapping up sale of its major international assets, Fortis Healthcare 's Singapore-based arm will offload 100 per cent stake in RadLink for SGD 111 million (over Rs 530 crore) to Fullerton Healthcare Group.

Fortis Healthcare to sell RadLink for over Rs 530 cr


Wrapping up sale of its major international assets, Fortis Healthcare 's Singapore-based arm will offload 100 per cent stake in RadLink for SGD 111 million (over Rs 530 crore) to Fullerton Healthcare Group.

Fortis Healthcare International, a step-down subsidiary of Fortis Healthcare, announced its decision to divest 100 per cent shareholding in RadLink-Asia and its subsidiaries, the company said in a statement.

The deal will be completed by May 12, it added.

RadLink provides diagnostic and molecular imaging services.

In a joint statement, Fortis Healthcare Executive Chairman Malvinder Singh and Executive Vice-Chairman Shivinder Singh said: "The significant value that we have created in our international healthcare businesses is now being unlocked and will be ploughed back to strengthen our growth in India."

RadLink was acquired in 2012-13 and "the divestment of this last major international business is in line with our strategic decision to intensify our focus on our core hospital and diagnostics business in India," they added.

JP Morgan and Religare Capital Markets acted as financial advisors to Fortis for this transaction.

Last year, Singapore's competition authority had sought a more detailed review of Fortis' plan to exit from RadLink saying the deal significantly reduced the number of providers of radiology and imaging services.

In 2013, it completed the sale of entire 65 per cent stake in Vietnam-based hospital chain Fortis Hoan My Medical Corporation for $80 million. The healthcare firm had also sold its stake in Hong Kong-based Quality Healthcare to Bupa for $355 million.

In 2012, Fortis Healthcare International had sold 64 per cent stake in Dental Corporation Holdings, Australia, to Bupa, for AUD 270 million.

Previous Page Next Page

People Searching On This Page:

Related Pages


M.Pharm Admission 2014 in Nirma University for GPAT/Non-GPAT Qualifiers

M.Pharm Admission 2014 in Nirma University for GPAT/Non-GPAT Qualifiers

Articles | Pharmacy Colleges
Date:
20-May-2014  Views: 3679

Nirma University, Ahmedabad was established in the year 2003 as a Statutory University under the Gujarat State Act at the initiative of the Nirma Educ ...
Hospital Pharmacist Jobs in Fortis Healthcare Ltd

Hospital Pharmacist Jobs in Fortis Healthcare Ltd

Jobs | Pharmacist Jobs | Banglore
Date:
14-Jan-2014  Views: 2353

Fortis Healthcare Limited is committed to clinical excellence and patient-centric healthcare, which is manifest in hospital design, patient services, ...
Pharmaceutical Machines Manufacturers & Suppliers in Delhi

Pharmaceutical Machines Manufacturers & Suppliers in Delhi

Articles | Pharma Suppliers | Delhi
Date:
06-Aug-2013  Views: 1426

Pharmaceutical industry is one the most promising and one the fastest growing industries of the country. The demand for pharmaceutical machines, equip ...
Walk in recritement of RSM, ASM and MRs at Overseas Healthcare

Walk in recritement of RSM, ASM and MRs at Overseas Healthcare

Jobs
Date:
12-Jul-2010  Views: 2134

Candidate should be science/pharmacy graduate with relevent experience. Freshers with good communication skills may also apply. ...
Walk in Interview for the post of Medical Transcriptionist at ELICO Ltd. | Freshers

Walk in Interview for the post of Medical Transcriptionist at ELICO Ltd. | Freshers

Jobs
Date:
12-Jul-2010  Views: 3362

urgent requirement for “Medical Transcriptionist Freshers” for Health Care BPO Division., with good listening and typing skills ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

32  + 5 =     
Comments

Google : 29 times | Yahoo : 14 times | Bing : 6 times |